Glenmark introduces higher strength (400 mg) of FabiFlu(R) to reduce the pill burden of COVID-19 treatment
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a…
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a…
Adani Power Ltd, a part of Adani Group, today announced the financial results[1] for the…
Mr. Beas Dev Ralhan, CEO and Co-Founder, Next Education India Pvt Ltd. The National Education…